≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Use of rasagiline

PheWeb

PDMED_RASAGILINE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04BD02

602

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

493

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

493

diagram downward connector

Include endpoints None

493

diagram downward connector
PDMED_RASAGILINE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 493 230 263
Unadjusted prevalence (%) 0.14 0.12 0.17
Mean age at first event (years) 64.85 63.88 65.69

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.10 6.20 [3.68, 10.43] 6.2e-12 68
15 years 0.02 2.74 [1.55, 4.82] 5.1e-4 30
5 years 0.01 7.10 [4.29, 11.76] 2.7e-14 35
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: PDMED_RASAGILINE – Use of rasagiline
GWS hits:

Survival analyses between endpoints

↥

Plot

before Use of rasagiline
after Use of rasagiline

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of rasagiline

↥